PolyU – Axis Therapeutics Joint Center for Immunotherapy Launched to Develop Innovative Cancer Treatments Read more
Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline Read more